Moreover, n-3 PUFAs also improved insulin signal pathway via modulating membrane fluidity and decreased proinflammatory responses via reducing the levels of TNF-α and IL-6 in NAFLD (133). Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.